Epidemiologic and Genetic Study on Familial Prostate Cancer
About this study
The aims of the study are: * to identify genetic and molecular factors (rare mutations, polymorphisms) involved in the natural history of prostate cancers and their response to treatment, * to evaluate and deduce their medical applications for screening and therapeutic management of these tumors.
- Condition
- Prostate Cancer
- Sponsor
- Centre de Recherche sur les Pathologies Prostatiques
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
Inclusion 5
- Minimum age: 18 years
- Study condition: Prostate Cancer
- patient with a histological confirmed prostate cancer
- member of a hereditary prostate cancer family
- healthy control men without prostate cancer
Exclusion 2
- Absence of signed informed consent
- refusal to participate in the study
Where
5 sites, 4 recruiting
Department of Urology, CHU Angers
Angers, France
Department of Urology, Hopital de la Cavale Blanche
Brest, France
Department of Urology, CHU Dijon
Dijon, France
Department of Urology, Hopital Pitié-Salpetriere
Paris, France
Department of Urology, Hopital Tenon
Paris, France
Contact
-
Olivier Cussenot, MD, PhD
00 33 1 56 01 76 46 olivier.cussenot@cerepp.org
-
Geraldine Cancel-Tassin, PhD
00 33 1 56 01 76 46 g.cancel@cerepp.org
Potential match only. Final eligibility is determined by the study team.